Skip to main content
SpringerLink
Log in

Transplantation

  • Chapter
Nutrition in Kidney Disease

Part of the book series: Nutrition and Health ((NH))

  • 1533 Accesses

Summary

Kidney transplantation is the preferred method of treatment for patients with stage 5 chronic kidney disease (CKD), and it is the most common solid organ transplant. Nutritional care of the kidney transplant recipient is a dynamic process. It involves the integration of clinical guidelines related to the care of CKD. A complete evaluation of the patient’s nutritional status before transplantation is imperative to identify deficits and correct abnormalities. Continual reassessment of the nutrition goals and efficacy of medical nutrition therapy (MNT) will enable the adjustment of nutrition priorities during different phases of kidney transplant care. The registered dietitian is a valued member of the transplant team and, by providing timely MNT, he/she can enhance the transplant recipient’s ability to prevent or minimize the nutrition-related complications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Organ Procurement and Transplantation Network. View data reports. Available at: http://www.optn.org. Accessed April 14, 2006.

    Google Scholar 

  2. Kumar MR, Coulston AM. Nutritional management of the cardiac transplant patient. J Am Diet Assoc 1983;83:463–465.

    PubMed  CAS  Google Scholar 

  3. Aguilar-Salinas CA, Diaz-Polanco A, Quintana E, Macias N, Arellano A, Ramirez E, Ordonez ML, Velasquez-Alva C, Gomez Perez FJ, Alberu J, Correa-Rotter R. Genetic factors in the pathogenesis of hyperlipidemia posttransplantation. Am J Kidney Dis 2002;40:169–177.

    Article  PubMed  Google Scholar 

  4. Baltar J, Ortega T, Ortego F, Laures A, Rebollo P, Gomez E, Alvarez-Grande J. Posttransplantation diabetes mellitus: prevalence and risk factors. Transplant Proc 2005;37:3817–3818.

    Article  PubMed  CAS  Google Scholar 

  5. Martins C, Pecoits-Filho R, Riella MC. Nutrition for post-renal transplant recipients. Transplant Proc 2004; Jul–Aug, 36(6):1650–1654.

    Google Scholar 

  6. Massarweh NN, Clayton JL, Mangum CA, Florman SS, Slakey DP. High body mass index and short and long-term renal allograft survival in adults. Am J Transplant 2006; 6(2):357–363.

    Article  Google Scholar 

  7. Seagraves A, Moore EE, Moore FA, Weil R, III. Net protein catabolic rate after kidney transplantation: impact of corticosteroid immunosuppression. JPEN J Parenter Enteral Nutr 1986;10:453–455.

    PubMed  CAS  Google Scholar 

  8. Jequler E. Energy, obesity and body weight standards. Am J Clin Nutr 1987;45:1035.

    Google Scholar 

  9. Glynn C, Greene G, Winkler M, Albina J. Predictive versus measured energy expenditure using limits-of-agreement analysis in hospitalized, obese patients. JPEN J Parenter Enteral Nutr 1999;23:147–154.

    Article  PubMed  CAS  Google Scholar 

  10. Hasse JM, Weseman RA. Solid organ transplantation: In: Gottschlich MM, Fuhrman MP, Hammond KA, Holcombe BJ, Seidner DL, eds. Nutrition Support Dietetics Core Curriculum. Dubuque, Iowa: ASPEN, 2001, p. 605.

    Google Scholar 

  11. Blue LS. Nutrition considerations in kidney transplantation. Top Clin Nutr 1992;7:7–23.

    Google Scholar 

  12. Blue LS. Adult kidney transplantation. In: Hasse JM, Blue LS, eds. Comprehensive Guide to Transplant Nutrition. Chicago, IL: American Dietetic Association, 2002, p. 49.

    Google Scholar 

  13. Rosenberg ME. Nutrition and transplantation. Kidney 1986;18:19.

    Google Scholar 

  14. Mahajan SK, Prasad AS, Rabbani P, Briggs WA, McDonald FD. Zinc deficiency: a reversible complication of uremia. Am J Clin Nutr 1982;36:1177–1183.

    PubMed  CAS  Google Scholar 

  15. Sandstead HH. Trace elements in uremia and hemodialysis. Am J Clin Nutr 1980;33:1501–1508.

    PubMed  CAS  Google Scholar 

  16. Thakur V, Kumar R, Dhawan IK. Correlation between serum magnesium and blood cyclosporine A concentrations in renal transplant recipients. Ann Clin Biochem 2002;39:70–72.

    Article  PubMed  CAS  Google Scholar 

  17. Bell. AD. Herbal medicine and the transplant patient. Nephrol Nurs J 2002;29:269–274.

    Google Scholar 

  18. Dietary Supplement Health and Education Act of 1994. US Food and Drug Administration, Center for Food Safety and Applied Nutrition. Available at: http://vm.cfsan.fda.gov/∼ dms/dietsupp.html. Accessed April 12, 2006.

    Google Scholar 

  19. Ruschitzka F, Meier PJ, Turina M. Acute heart transplant rejection due toSt. John’s wort. Lancet 2000;355:548–549.

    Article  PubMed  CAS  Google Scholar 

  20. DiCecco SR, Francisco-Ziller N, Moore D. Overview and immunosuppression. In: Hasse JM, Blue LS, eds. Comprehensive Guide to Transplant Nutrition. Chicago, IL: American Dietetic Association, 2002, pp. 1–30

    Google Scholar 

  21. Ponticello C, Passenni P. Gastrointestinal complications in renal transplant recipients. Transpl Int 2005;18(6):643–650.

    Article  Google Scholar 

  22. Bardaxoglou E, Maddern G, Ruso L, Siriser F, Campion JP, Le Pogamp P, Catheline JM, Launois B. GI surgical emergencies following kidney transplantation. Transpl Int 1993;6:148–152.

    Article  PubMed  CAS  Google Scholar 

  23. Mosimann F, Cuenoud PF, Steinhauslin F, Wauters JP. Herpes simplex esophagitis after renal transplantation. Transpl Int 1994;7:79–82.

    Article  PubMed  CAS  Google Scholar 

  24. Troppman C, Papalois BE, Chiou A, Benedetti E, Dunn DL, Matas AJ, Najarian JS, Gruessner RW. Incidence, complications, treatment, and outcome of ulcers of the upper GI tract after renal transplantation during the CsA era. J Am Coll Surg 1995;80:433–443.

    Google Scholar 

  25. Ozgur O, Boyacioglu S, Ozdogan M, Gur G, Telatar H, Haberal M. Helicobacter pylori infection in haemodialysis patients and renal transplant recipients. Nephrol Dial Transplant 1997;12:289–291

    Article  PubMed  CAS  Google Scholar 

  26. Torres A, Lorenzo V, Salido E. Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol 2002;13:551–558.

    PubMed  Google Scholar 

  27. Drug Facts and Comparisons. St Louis, MO: Wolters Kluwer, 2000.

    Google Scholar 

  28. Beto J, Bansal VK. Hyperkalemia: evaluating dietary and nondietary etiology.J Ren Nutr 1992;1;28–29.

    Google Scholar 

  29. Rubello D, Giannini S, D’Angelo A, Nobile M, Carraio G, Rigotti P, Marchini F, Zaninotto M, Dalle Carbonare L, Sartori L, Nibale O, Carpi A. Secondary hyperparathyroidism is associated with vitamin D receptor polymorphism and bone density after renal transplantation. Biomed Pharmacother 2005 Aug;59(7): 402–407.

    Google Scholar 

  30. Palmer SC, Strippoli GF, McGregor DO. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. Am J Kidney Dis 2005 Apr;45(4):638–649.

    Google Scholar 

  31. Torres A, Lorenzo V, Salido E. Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol 2002;13:551–558.

    PubMed  Google Scholar 

  32. Messa P, Sindici C, Cannella G, Miotti V, Risaliti A, Gropuzzo M, Di Loreto PL, Bresadola F, Mioni G. Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int 1998;54:1704–1713.

    Article  PubMed  CAS  Google Scholar 

  33. Querings K, Girndt M, Geisel J, Georg T, Tilgen W, Reichrath J. 25-hydroxyvitamin D deficiency in renal transplant recipients. J Clin Endocrinol Metab 2006;91(2):526–529.

    Article  PubMed  CAS  Google Scholar 

  34. Haef J, Jakobsen V, Tuedegoard E, Kanstrupl L, Fogh-Anderson N. Dietary habits of nutritional status of renal transplant patients. J Ren Nutr 2004;14(1):20–25.

    Article  Google Scholar 

  35. Fisher JS, Woodle ES, Thistlethwaite JR. Kidney transplantation: graft monitoring and immunosuppression. World J Surg 2002;26:185–193.

    Article  PubMed  Google Scholar 

  36. Morris PJ. Cyclosporine. In: Morris PJ, ed. Kidney Transplantation: Principles and Practice. Philadelphia, PA: WB Saunders Co, 1994, pp. 179–201.

    Google Scholar 

  37. Bennett W, Burdmann E, Andoh T, Houghton D, Lindsley J, Elzinga L. Nephrotoxicity of immunosuppressive drugs. Nephrol Dial Transplant 1994;9:141–145.

    PubMed  Google Scholar 

  38. Kahan B. Cyclosporine. N Engl J Med 1989;321:1725–1738.

    PubMed  CAS  Google Scholar 

  39. Gelone DK, Lake KD. Transplantation pharmacotherapy. In: Cupples SA, Ohler L, eds. Solid Organ Transplantation: A Handbook for Primary Health Care Providers. New York, NY: Springer Publishing, 2002, pp. 114–116.

    Google Scholar 

  40. Gonzalez-Posada JM, Rodriquez AP, Tamajon P, Hdez-Marrero D, Maceira B. Immunosuppression with sirolimus, cyclosporine and prednisone in renal transplantation. Transplant Proc 2002;34:99.

    Google Scholar 

  41. Starzl T, Marchiono T, Waddell W. The reversal of rejection in human renal homografts with subsequent development of homograft tolerance. Surg Gynecol Obstet 1963;117:385–395.

    PubMed  CAS  Google Scholar 

  42. Gelone DK, Lake KD. Transplantation pharmacotherapy. In: Cupples SA, Ohler L, eds. Solid Organ Transplantation: A Handbook for Primary Health Care Providers. New York, NY: Springer Publishing, 2002, pp. 120–121.

    Google Scholar 

  43. McCann L. Pocket Guide to Nutrition Assessment of the Patient with Chronic Kidney Disease, 3rd edn. Redwood City, CA: Satellite Healthcare, 2002.

    Google Scholar 

  44. Vincenti F, Nashan B, Light S. Double Therapy and the Triple Therapy Study Groups. Daclizumab: outcome of phase III trials and mechanisms of action. Transplant Proc 1998;30:2155–2158.

    Article  PubMed  CAS  Google Scholar 

  45. Kahan B, Rajagopalan P, Hall M. Reduction of the occurrence of acute cellular rejection among renal allografts recipients treated with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody. Transplantation 1999;67: 276–284.

    Article  PubMed  CAS  Google Scholar 

  46. Kasiske, B, Cosio FG, Beto J, Bolton K, Chavers BM, Grimm R, Levin A, Masri B, Parekh R, Wanner C, Wheeler DC, Wilson PWF. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant 2004;4(Suppl 7):13–53.

    Article  PubMed  Google Scholar 

  47. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2004. Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/. Accessed by April 14 2006.

    Google Scholar 

  48. Martinez-Castelao, A, Grinyo JM, Gil-Vernet S, Seron D, Castineiras MJ, Ramos R, Alsina J. Lipid-lowering long-term effects of six different statins in hypercholesterolemic renal transplant patients under cyclosporine immunosuppression. Transplant Proc 2002;34:398–400.

    Article  PubMed  CAS  Google Scholar 

  49. Savaj S, Ghorbani G, Ghoda AJ. Hyperhomocysteinemia in renal transplant recipients. Transplant Proc 2002;33:2701.

    Article  Google Scholar 

  50. Mor E, Helfmann L, Lustig S, Bar-Nathan N, Yussim A, Sela BA. Homocysteine levels among transplant recipients: effect of immunosuppressive protocols. Transplant Proc 2001;33:2945–2946.

    Article  PubMed  CAS  Google Scholar 

  51. Zantvoort FA, Waldeman J, Colic D, Lison AE. Incidence and treatment of hyperhomocysteinemia after renal transplantation. Transplant Proc 2001;33: 3679–3680.

    Article  PubMed  CAS  Google Scholar 

  52. Merouani A, Rozen R, Clermont MJ, Genest J. Renal function, homocysteine and other plasma thiol concentrations during the postrenal transplant period. Transplant Proc 2002;34:1159–1160.

    Article  PubMed  CAS  Google Scholar 

  53. Friedman AN, Rosenberg IH, Selhub J, Levey AS, Bostom AG. Hyperhomocysteinemia in renal transplant recipients. Am J Transplant 2002;2:308–313.

    Article  PubMed  CAS  Google Scholar 

  54. Savaj S, Rezakhani S, Porooshani F, Ghods AJ. Effect of folic acid therapy on serum homocysteine level in renal transplant recipients. Transplant Proc 2002;34:2419.

    Article  PubMed  CAS  Google Scholar 

  55. Arnadottir M, Hultberg B, Vladov V, Nilsson-Ehle P, Thysell H. Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients. Transplantation 1996;61:509–512.

    Article  PubMed  CAS  Google Scholar 

  56. Hricik DE. Weight gain after kidney transplantation. Am J Kidney Dis 2001;38:409–410.

    Article  PubMed  CAS  Google Scholar 

  57. Hasse JM. Nutritional issues in adult transplantation. In: Cupples SA, Ohler L, eds. Solid Organ Transplantation: A Handbook of Primary Health Care Providers. New York, NY: Springer Publishing, 2002, pp. 64–87.

    Google Scholar 

  58. Clunk J, Lin C, Curtis J. Variables affecting weight gain in renal transplant recipients. Am J Kidney Dis 2001;73:53–55.

    Google Scholar 

  59. Patel MG. The effect of dietary intervention on weight gains after renal transplantation. J Ren Nutr 1998;8:137–141.

    Article  PubMed  CAS  Google Scholar 

  60. Bernadi A, Biasia F, Pati T, Piva M, Scaramuzzo P, Stoppa F, Bucciante G. Factors affecting nutritional status, response to exercise and progression of chronic rejection in kidney transplant recipients. J Ren Nutr 2005;15(1):54–57.

    Article  Google Scholar 

  61. Sezar S, Bilgic A, Uvar M, Arat Z, Ozdemir FN, Haberal M. Risk factors for development of posttransplant diabetes mellitus in renal transplant recipients. Transplant Proc 2006;38(2):529–532.

    Article  CAS  Google Scholar 

  62. Markell MS. Post-transplant diabetes: incidence, relationship to choice of immunosuppressive drugs, and treatment protocol. Adv Ren Replace Ther 2001;8:64–69.

    Article  PubMed  CAS  Google Scholar 

  63. Davidson J, Wilkinson A, Danta J, et al. New onset diabetes after transplantation: International Consensus Guidelines. Transplantation 2003;75(10):SS3–24.

    Article  PubMed  Google Scholar 

  64. Schwenger V, Zeier M, Ritz E. Hypertension after renal transplantation. Ann Transplant 2001;6:25–30.

    PubMed  CAS  Google Scholar 

  65. Zeier M, Dikow R, Ritz E. Blood pressure after renal transplantation. Ann Transplant 2001;6:21–24.

    PubMed  CAS  Google Scholar 

  66. Hollander A, van Rooij J, Lentjes E, Arbouw F, van Bree J, Schoemaker R, van Es L, van der Woude F, Cohen A. The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients. Clin Pharmacol Ther 1995;57:318–324.

    Article  PubMed  CAS  Google Scholar 

  67. Bailey DG, Malcolm J, Arnold O, Spence JD. The effect of grapefruit juice on CsA and prednisone metabolism in transplant patients. Br J Clin Pharmacol 1998;46:101–110.

    Article  PubMed  CAS  Google Scholar 

  68. National Institute of Allergy and Infectious Diseases. National Institutes of Health. Fact Sheet: Foodborne Diseases. February 2005. Available at: http://www.niaid.nih.gov/factsheets/foodbornedis.htm. Accessed April 14, 2006.

    Google Scholar 

  69. Daniels N, Shafie A. A review of pathogenic vibrio infections for clinicians.J Infect Med 2000;17:665–685.

    Google Scholar 

  70. US Food and Drug Administration, Center for Food Safety and Applied Nutrition. Foodborne Pathogenic Microorganisms and Natural Toxins Handbook, Bag Bug Book. (2000) Available at: http://www.cfsan.fda.gov/∼ mow/intro.html. Accessed April 14, 2006.

    Google Scholar 

  71. US Environmental Protection Agency. Safe drinking water – guidance for people with severely weakened immune systems. June 1999. Available at: http://www.epa.gov/OGWDW/crypto.html. Accessed April 14, 2006.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Genzyme Renal, Vermilion, Ohio

    Pamela S. Kent MS, RD, CSR, LD

Authors
  1. Pamela S. Kent MS, RD, CSR, LD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Nutritional Sciences, University of Medicine and Dentistry of New Jersey, 40 East Laurel Rd, Stratford, NJ, USA

    Laura D. Byham-Gray

  2. Division of Nephrology, Stanford University School of Medicine, 3333 California St, Stanford, CA, USA

    Glenn M. Chertow

  3. Department of Nutrition, C.W. Post Campus Long Island University, 720 Northern Blvd, Brookville, NY, USA

    Jerrilynn D. Burrowes

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, Totowa, NJ

About this chapter

Cite this chapter

Kent, P.S. (2008). Transplantation. In: Byham-Gray, L.D., Chertow, G.M., Burrowes, J.D. (eds) Nutrition in Kidney Disease. Nutrition and Health. Humana Press. https://doi.org/10.1007/978-1-59745-032-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-032-4_10

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-781-5

  • Online ISBN: 978-1-59745-032-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation